- Title
- In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms (vol 8, pg 568, 2018)
- Creators
- Jessica L. F. TehPhil F. ChengTimothy J. PurwinNeda NikbakhtPrem PatelInna ChervonevaAdam ErtelPaolo M. FortinaInes KleiberKim HooKimMichael A. DaviesLawrence N. KwongMitch P. LevesqueReinhard DummerAndrew E. Aplin
- Publication Details
- Cancer discovery, v 8(12), pp 1654-1654
- Publisher
- Amer Assoc Cancer Research
- Number of pages
- 1
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems
- Web of Science ID
- WOS:000452367300030
- Scopus ID
- 2-s2.0-85058005322
- Other Identifier
- 991019176803404721
Journal article
In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms (vol 8, pg 568, 2018)
Cancer discovery, v 8(12), pp 1654-1654
01 Dec 2018
PMID: 30510016
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Oncology